Roche Holding Non-GAAP EPS of CHF 19.46, revenue of CHF 61.52B; issues FY26 outlook
Source: SeekingAlpha
2026-01-29 01:37:52 ET
More on Roche Holding
- Roche's CT-388 Adds Optionality In The GLP Market, But Wait For Dips
- Roche Is The 'Value Play' Of The 2026 Obesity Gold Rush
- Roche: Important De-Risking Of CT-388 In Obesity, Petrelintide Is Next
- Genentech sees strong phase 2 results for obesity treatment CT-388
- Roche more than doubles investment in new North Carolina site
Read the full article on Seeking Alpha
For further details see:
Roche Holding Non-GAAP EPS of CHF 19.46, revenue of CHF 61.52B; issues FY26 outlook
Roche Holding Div Rts
NASDAQ: RHHVF
RHHVF Trading
0.81% G/L:
$407.172 Last:
2,447 Volume:
$409.635 Open:
RHHVF Latest News
RHHVF Stock Data
$365,070,204,381
800,578,845
N/A
1789
N/A
Pharmaceuticals
Healthcare
CH
Basel Switzerland
